Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LE-DT in locally advanced or metastatic pancreatic cancer
NCT01186731Phase 2Completed
- Sponsor
- Insys Therapeutics
- Start
- Apr 2010
- Primary completion
- Apr 2011
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of liposome entrapped docetaxel in pancreatic cancer (PC), sponsored by Insys Therapeutics. Started Apr 2010; status: completed.
02
Drugs
liposome entrapped docetaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01186731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01186731.